"Designing Growth Strategies is in our DNA"

U.S. Viral Clearance Market Size, Share & Industry Analysis, By Method (Viral Removal Method, Viral Inactivation Method, and Viral Detection Method), By Application (Blood and Blood Products, Recombinant Proteins, Cellular & Gene Therapy Products, Vaccines, and Others), By End-user (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CRO), and Others), and Country Forecast, 2024-2032

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI107888

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Technological Advancements in Viral Clearance Methods
    2. Regulatory Scenario, U.S.
    3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    4. Impact of COVID-19 on the Market
  5. U.S. Viral Clearance Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Method
      1. Viral Removal Method
      2. Viral Inactivation Method
      3. Viral Detection Method
    2. Market Analysis, Insights and Forecast – By Applications
      1. Blood and Blood Products
      2. Recombinant Proteins
      3. Cellular & Gene Therapy Products
      4. Vaccines
      5. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Pharmaceutical and Biotechnology Companies 
      2. Academic & Research Institutes
      3. Contract Research Organizations (CRO)
      4. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis
    2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Merck KGaA
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Wuxi Biologics
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Charles River Laboratories
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Texcell
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Kedrion
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Clean Cells
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. ViruSure GmbH
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Sartorius AG
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Syngene International Limited
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. Microbiologics
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Technological Advancements in Viral Clearance Methods
    2. Regulatory Scenario, U.S.
    3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    4. Impact of COVID-19 on the Market
  5. U.S. Viral Clearance Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Method
      1. Viral Removal Method
      2. Viral Inactivation Method
      3. Viral Detection Method
    2. Market Analysis, Insights and Forecast – By Applications
      1. Blood and Blood Products
      2. Recombinant Proteins
      3. Cellular & Gene Therapy Products
      4. Vaccines
      5. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Pharmaceutical and Biotechnology Companies 
      2. Academic & Research Institutes
      3. Contract Research Organizations (CRO)
      4. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis
    2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Merck KGaA
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Wuxi Biologics
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Charles River Laboratories
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Texcell
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Kedrion
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Clean Cells
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. ViruSure GmbH
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Sartorius AG
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Syngene International Limited
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. Microbiologics
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Table 01: U.S. Viral Clearance Market Revenue (USD million) Forecast, By Method, 2019-2032

Table 02: U.S. Viral Clearance Market Revenue (USD million) Forecast, By Application, 2019-2032

Table 03: U.S. Viral Clearance Market Revenue (USD million) Forecast, By End-user, 2019-2032

Table 04: U.S. Viral Clearance Market Revenue (USD million) Forecast, By Region, 2019-2032

 

Figure 01: U.S. Viral Clearance Market Revenue Breakdown (USD million, %) by Method, 2023 & 2032

Figure 02: U.S. Viral Clearance Market Value Share (%), By Method, 2023 & 2032

Figure 03: U.S. Viral Clearance Market Value Share (%), By Application, 2023 & 2032

Figure 04: U.S. Viral Clearance Market Value Share (%), By End-user, 2023 & 2032

Figure 05: U.S. Viral Clearance Market Value Share (%), By Region, 2023 & 2032

Figure 06: U.S. Viral Clearance Market Share (%), By Company, 2023

U.S. Viral Clearance Market
  • 2019-2032
  • 2023
  • 2019-2022
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports